Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Dodge & Cox 60.39M $3.23B March 31, 2014
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Royal Bank of Canada 14.10M $753.46M March 31, 2014
Fisher Investments 11.37M $607.85M June 30, 2014
STATE STREET CORPORATION 10.88M $581.43M March 31, 2014
Bank of America Corporation 9.21M $492.05M March 31, 2014
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
T. Rowe Price Associates 9.00M $480.75M March 31, 2014
Wells Fargo & Company 8.47M $452.59M March 31, 2014
Renaissance Technologies 7.01M $374.53M March 31, 2014
FMR 6.59M $352.27M March 31, 2014
FIDUCIARY MANAGEMENT INC /WI/ 6.01M $321.32M March 31, 2014
Inves 5.59M $298.51M March 31, 2014
Allianz Global Investors of America 5.45M $244.61M March 31, 2012
Tradewinds Global Investors 5.17M $240.43M Dec. 31, 2011

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Brandes Investment Partners Dec. 31, 2010 5.11M $200.22M